Search results for "Osteopenia"

Antifracture effects of zoledronate persist for up to 3.5 years, study suggests

Fracture rates rose from 15 per 1,000 woman-years in the last two years of a six-year trial to 24 fractures in the first two years of follow-up. In the next two years of follow-up, the rate substantially increased to 42 fractures per 1,000 woman-years.
https://immattersacp.org/weekly/archives/2024/03/12/4.htm
12 Mar 2024